Vitamin D deficiency associated with lowest retention rates of first bDMARD in PsAApril 18, 2023Psoriatic Arthritis
Distinct clinical manifestations of PsA with axial involvement and axial spondyloarthritis with psoriasisApril 18, 2023Psoriatic Arthritis
Triglyceride-glucose index: A promising atherosclerotic marker in PsAApril 18, 2023Psoriatic Arthritis
Does COVID-19 vaccination worsen disease activity in PsA patients on targeted therapy?April 18, 2023Psoriatic Arthritis
Rheumatology NewsNew 46-week PsA data released for IL-17A inhibitor izokibepApril 12, 2023Psoriatic Arthritis
Commentary: Disease activity, JAK inhibitors, and pregnancy risks in PsA, April 2023March 30, 2023Psoriatic Arthritis
Rheumatology NewsBiosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicineRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsLupus & Connective Tissue DiseasesAnkylosing spondylitis
Rheumatology NewsFDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023Rheumatoid ArthritisPsoriatic ArthritisPediatricsAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsNew data forecast more oral PDE4 inhibitors for psoriasisMarch 27, 2023Psoriatic Arthritis
Apremilast safe and effective in biologic-naive patients with early PsAMarch 23, 2023Psoriatic Arthritis
Concurrent onset of skin and joint symptoms tied to high disease activity in PsAMarch 23, 2023Psoriatic Arthritis
Ultrasound helps screen patients with moderate-to-severe psoriasis progressing to subclinical PsAMarch 23, 2023Psoriatic Arthritis
